Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.01B |
| 2 |
Dell
DELL
|
+$705M |
| 3 |
T-Mobile US
TMUS
|
+$643M |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$621M |
| 5 |
Palantir
PLTR
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.41B |
| 2 |
Walmart Inc
WMT
|
+$1.29B |
| 3 |
NVIDIA
NVDA
|
+$1.29B |
| 4 |
Apple
AAPL
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$974M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.65% |
| 2 | Financials | 0.97% |
| 3 | Industrials | 0.85% |
| 4 | Consumer Discretionary | 0.81% |
| 5 | Healthcare | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5901
Fidelity Momentum Factor ETF
FDMO
$892M
| $1.29M | ﹤0.01% |
+16,078
| New | +$1.35M |
|
5902
Mettler-Toledo International
MTD
$28.1B
| $1.29M | ﹤0.01% |
1,021
-23,131
| -96% | -$31.2M |
|
5903
Invesco BulletShares 2032 Corporate Bond ETF
BSCW
$1.48B
| $1.29M | ﹤0.01% |
62,500
+28,737
| +85% | +$599K |
|
|
PFN
5904
PIMCO Income Strategy Fund II
PFN
$695M
| $1.29M | ﹤0.01% |
186,732
+109,718
| +142% | +$794K |
|
5905
ActivePassive Core Bond ETF
APCB
$1.01B
| $1.29M | ﹤0.01% |
+43,666
| New | +$1.3M |
|
|
QQA
5906
Invesco QQQ Income Advantage ETF
QQA
$746M
| $1.29M | ﹤0.01% |
25,781
-32,963
| -56% | -$1.72M |
|
5907
PUT
Matthews International
MATW
$887M
| $1.29M | ﹤0.01% |
49,800
+28,100
| +129% | +$737K |
|
5908
PUT
Aurora
AUR
$11.7B
| $1.28M | ﹤0.01% |
311,800
+218,000
| +232% | +$964K |
|
5909
Critical Metals Corp
CRML
$754M
| $1.28M | ﹤0.01% |
161,492
+95,032
| +143% | +$1.09M |
|
5910
PUT
iShares Core S&P Total US Stock Market ETF
ITOT
$92.3B
| $1.28M | ﹤0.01% |
+9,000
| New | +$1.34M |
|
|
BTCZ
5911
T-Rex 2X Inverse Bitcoin Daily Target ETF
BTCZ
$19.9M
| $1.28M | ﹤0.01% |
234,343
+196,408
| +518% | +$983K |
|
5912
iShares Global Consumer Staples ETF
KXI
$1.09B
| $1.28M | ﹤0.01% |
+19,127
| New | +$1.32M |
|
5913
Lyell Immunopharma
LYEL
$318M
| $1.28M | ﹤0.01% |
63,893
+51,484
| +415% | +$1.2M |
|
5914
CALL
Tilray
TLRY
$543M
| $1.28M | ﹤0.01% |
198,070
-60,810
| -23% | -$474K |
|
5915
PUT
Legend Biotech
LEGN
$3.65B
| $1.28M | ﹤0.01% |
70,800
-4,000
| -5% | -$76.3K |
|
5916
Karat Packaging
KRT
$810M
| $1.28M | ﹤0.01% |
45,840
+27,715
| +153% | +$698K |
|
|
GTM
5917
CALL
ZoomInfo Technologies
GTM
$1.03B
| $1.28M | ﹤0.01% |
214,000
+139,700
| +188% | +$1.03M |
|
5918
Fidus Investment
FDUS
$759M
| $1.28M | ﹤0.01% |
73,454
-36,304
| -33% | -$678K |
|
5919
CALL
Privia Health
PRVA
$3.04B
| $1.28M | ﹤0.01% |
+62,200
| New | +$1.4M |
|
5920
Labcorp
LH
$25.2B
| $1.28M | ﹤0.01% |
4,794
-2,731
| -36% | -$740K |
|
5921
CALL
Iridium Communications
IRDM
$4.7B
| $1.28M | ﹤0.01% |
46,100
+8,700
| +23% | +$196K |
|
5922
NB Bancorp
NBBK
$993M
| $1.28M | ﹤0.01% |
60,669
-20,972
| -26% | -$441K |
|
5923
Aemetis
AMTX
$99.2M
| $1.28M | ﹤0.01% |
400,673
+217,756
| +119% | +$396K |
|
5924
CALL
ArriVent BioPharma
AVBP
$1.4B
| $1.28M | ﹤0.01% |
+55,400
| New | +$1.25M |
|
5925
CALL
Vanguard FTSE Europe ETF
VGK
$30.1B
| $1.28M | ﹤0.01% |
15,500
+3,600
| +30% | +$309K |
|
Similar funds
Jane Street's Q1 2026 Portfolio in Review
As of Q1 2026, Jane Street held 13,677 positions worth $777B, up 17% from $662B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street deployed $153B of net new capital in Q1 2026, opening 2,619 new positions and adding to 4,818 existing holdings. Its largest new stake was iShares Core US Aggregate Bond ETF: 2,411,981 shares worth $239M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 2.8% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.41B trimmed.
- Jane Street's largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 2,411,981 shares worth $239M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $7.01B increase.
- Jane Street's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $1.41B.
- Jane Street fully exited VanEck Gold Miners ETF in Q1 2026, selling an estimated $265M.
- Jane Street's ten largest holdings make up 34% of its $777B portfolio in Q1 2026.
- Jane Street opened 2,619 new positions and closed 2,274 in Q1 2026.
- Jane Street's portfolio value rose 17% quarter-over-quarter to $777B.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.